The GPCRdb contains data, diagrams and web tools for G protein-coupled receptors (GPCRs). This resource was founded by professor Gert Vriend, theme Nanomedicine, and is now maintained and expanded by the group of David Gloriam in Copenhagen.
GPCRs are cell-surface receptors, and they are a very important drug target: 34% of all drugs approved in the US act on GPCRs. For rational drug design, structures of the receptors are needed. GPCRs are difficult to crystallize, because they are very flexible and hydrophobic. In the past decade, much progress has been made in measuring GPCR structures, but there is no structure for the majority of receptors (87%) and there is a lack in knowledge about the intermediate and active states of GPCRs. The GPCRdb now offers a tool that helps to design mutations, choose fusion proteins and choose experimental conditions in order to successfully crystallize a receptor.
Related news items

Large NWA ORC grant awarded for national skin research: Next Generation ImmunoDermatology
23 March 2022Research for better treatment methods for chronic skin diseases.
read more
Metakids-UMD grant for Purva Kulkarni
18 June 2020 The Metakids foundation has awarded 220.575 Euro to support the establishment of a multi-omics biomarker platform within the United for Metabolic Disease (UMD) consortium. read more
UMCs work together on the FAIRification of patient registries
4 June 2020 It has become easier for scientists working with rare diseases to exchange research data. By researchers from Radboudumc and Amsterdam UMC, a rare disease registry codebook has been created. The codebook facilitates data exchange between institutions with different electronic data capture software. read more
The new front line: big data podcast
22 May 2020 What role do big data and technology play in the fight against corona? What data can help save lives? How do you ensure that your personal health data is used safely? Among others, Peter-Bram 't Hoen explains. read more
MetaDome highly accessed
7 May 2020MetaDome was recently recognized as one of the most accessed articles of 2018-2019 in Human Mutation. The MetaDome was a project developed by Laurens van de Wiel, Christian Gilissen, and Gert Vriend.
read more
Towards molecular therapies for Myotonic Dystrophy
1 October 2019ReCognitION, a new 1.3 M€ European project under the leadership of Peter-Bram ‘t Hoen, Baziel van Engelen and Jeffrey Glennon, was kicked-off in Gent.
read more